August 1, 2019 — Less-invasive procedures to open severely clogged leg arteries were as good at helping people survive ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
June 13, 2019 — Silk Road Medical Inc. announced the presentation of real-world data for the treatment of patients with ...
May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
April 18, 2019 — The U.S. Food and Drug Administration published a draft guidance titled, “Technical Considerations for ...
April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack ...
April 15, 2019 — Biotronik began its U.S. commercial launch of the PK Papyrus covered coronary stent system for use in ...
April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...
April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...
April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...
February 22, 2019 — The U.S. Food and Drug Administration (FDA) has approved the Biotronik Orsiro drug-eluting stent ...
Clinical study data makes the world go around in cardiology and is the basis of setting guidelines in evidence-based ...
In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...
The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...
The rise cardiovascular disease has been instrumental in fueling the coronary stent market share in the past few years ...